Helix Nanotechnologies YC Başvurusu

Winter 2017Active

Helix Nanotechnologies, Healthcare şirketi olarak Winter 2017 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Winter 2017
Sektör: HealthcareDrug Discovery and Delivery
Ekip büyüklüğü: 22
Durum: Active
Lansmanı Yapıldı: 2016

Kurucular

Nikolai EroshenkoFounder/CSO

Helix Nanotechnologies ne yapar

Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech - moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.

Helix Nanotechnologies'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Helix Nanotechnologies, Winter 2017 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Helix Nanotechnologies

Describe what your company does in 50 characters or less.

Next-generation mRNA platform for disease and climate

What is your company going to make? Please describe your product and what it does or will do.

We are building an mRNA platform that improves the speed and cost of developing therapies. Our technology allows experiments that once took months or years to be done in weeks, and for thousands of dollars instead of millions. We are advancing a COVID-19 vaccine candidate for the immunocompromised and testing an intervention aimed at climate impact.

Where do you live now, and where would the company be based after YC?

We live and work in Boston and Cambridge, MA, and will base the company there after YC.

Explain your decision regarding location.

Boston and Cambridge are biotech hubs with deep scientific talent and collaborators. Being here helps us attract the right team and stay on the cutting edge of RNA technology.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, Helix Nanotechnologies şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Helix Nanotechnologies'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Helix Nanotechnologies gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.

Helix Nanotechnologies hangi YC grubundaydı?

Helix Nanotechnologies, Y Combinator Winter 2017 grubundaydı.

Helix Nanotechnologies kim tarafından kuruldu?

Helix Nanotechnologies, Nikolai Eroshenko tarafından kuruldu.

Helix Nanotechnologies ne iş yapar?

Next-generation mRNA platform to solve cancer, COVID and climate.

Tam yeniden oluşturulmuş başvuruyu nasıl okurum?

Ücretsiz bir Round Funded hesabı oluşturun. Helix Nanotechnologies'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.